Decoding MicrobiomeRevolutionising Treatment

GutSee Health is transforming the future of gut health by decoding complex gut signatures with cutting-edge science. Our revolutionary Ai Discovery platform fuses multi-omics data with Ai modelling to unlock complex microbiome-host interactions behind gut disorders. We go beyond symptoms, targeting the root cause with precision microbiome modulation therapy to restore gut balance and provide lasting relief.

Contact us

Our OfferingBespoke AIDiscovery platform

Contact us

Hundreds of millions of people have gut disorders globally with Irritable Bowel Syndrome affecting over 62 million people in the USA alone. GutSee is revolutionising the future of treating gut disorders by using cutting-edge science with Ai modelling.

Our revolutionary Ai Discovery platform enables complex analyses of Big-Data and Ai modelling revealing the molecular signature behind gut disorders, starting with Irritable Bowel Syndrome (IBS). Disrupted gut ecosystem can be rebalanced removing all IBS symptoms by using our microbiome therapy that reverts it back to health.

Effectiveness

Struggling to ensure your drug’s efficacy? Unlock better outcomes with targeted strategies.

Acceleration

Speed up pharmacokinetics research for faster, more accurate drug development breakthroughs.

 

.

Microbiome

Understand how the microbiome impacts drug pharmacokinetics for improved precision.

Selection

Optimise patient selection in clinical trials to enhance drug evaluation accuracy.

VideoAn Introduction

Our Solution

Targeted Microbiome Therapy

A disrupted gut microbiome is implicated in many gut disorders, including Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS). These diseases affect over 10 million patients in the UK, leading to 1.5-2 million workdays lost annually and costing the NHS £2 billion per year. There is currently no treatment for Irritable Bowel Syndrome, and existing symptom management approaches fail 40-60% of patients.

GutSee is a science-first company developing cutting-edge, targeted microbiome therapy aimed at rebalancing the disrupted gut microbiome and addressing the root cause of the problem.

Our therapy follows a 3-pronged approach:
  • ADD missing therapeutic bacterial consortia
  • REMOVE harmful bacteria
  • ENGINEER bacteria to produce metabolites or therapeutic agents
Contact us


62m+

IBS sufferers in USA



100m+

Global Gut disorder sufferers

ï‚®

15%

Proportion of UK affected by IBS

Team

Our Founding Team

Joanna Wiecek

CEO

Ketaki Mhatre

CSO

Josefina Cid

Senior Scientist

Paulina Bartasun

Head of R&D

Contact Us

Please Contact Our Team

News Updates

Our Latest News and Articles

Feb 1, 2025

Collaboration with St George’s University Hospital

Dr. Andrew Poullis at St George's University and GutSee Health are combining their expertise to explore how a disrupted microbiome contributes to gut disorders. GutSee's first clinical study will recruit 50 patients with Irritable Bowel Syndrome and Inflammatory...

Read More

Dec 12, 2024

GutSee featured in Genetic Modification documentary

Dr. Joanna, CEO and co-founder of GutSee Health, was featured in an exciting new production by the renowned director Arman Alizad, exploring groundbreaking technologies shaping the future of human health. The series, 7 Kuolemansyntiä, recently won the prestigious...

Read More

Sep 13, 2024

Zinc VC investment

GutSee Health, co-founded by Dr. Joanna Wiecek, a leading expert in microbiome research, has just secured initial venture capital investment to revolutionise the treatment of Irritable Bowel Syndrome and Inflammatory Bowel Disease. With this funding, the company is...

Read More